Tumor areas with high TROP2 expression showed homogeneously a strong nuclear H3K4me3 signal whereas tumor areas with low/no TROP2 expression showed a rather heterogeneous staining pattern for H3K4me3 with mostly weakly positive stained nuclei. The gene discussed is TACSTD2; the disease is neoplasm.